Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma

Daisuke Matsui, Ali H. Zaidi, Samantha A. Martin, Ashten N. Omstead, Juliann E. Kosovec, Luai Huleihel, Lindsey T. Saldin, Christina DiCarlo, Jan F. Silverman, Toshitaka Hoppo, Gene G. Finley, Stephen F. Badylak, Ronan J. Kelly, Blair A. Jobe

Research output: Contribution to journalArticle

Abstract

Esophageal adenocarcinoma (EAC) is an aggressive cancer necessitating the development of improved risk stratification tools for personalized care. Previously, microRNAs have been shown to correlate with the progression and prognosis of various cancer types; however, the value in EAC remains largely unexplored. We performed global microRNA profiling on 32 formalin-fixed, paraffin-embedded EAC specimens to identify microRNAs associated with progression. Literature search and pathway analysis further refined output to five significantly deregulated candidate biomarkers. Four of the five microRNAs (miR-652-5p, miR-7-2-3p, miR-3925-3p, and miR-219-3p) were validated by qRT-PCR. Survival outcomes were evaluated in testing set of 26 stage II/III EAC patients to determine the prognostic relevance of the selected microRNAs. In the testing set, miR-652-5p and miR-7-2-3p expressions were significantly associated with progression-free survival (p-value = .00771 and p-value = .00293). The highest area under receiver operating characteristic (ROC) curve was 0.8212 for the combination of miR-652-5p and miR-7-2-3p. Collectively, our findings demonstrated that the miR-652-5p/miR-7-2-3p signature may serve as a promising prognostic marker in patients with locally advanced EAC.

Original languageEnglish (US)
Pages (from-to)81281-81291
Number of pages11
JournalOncotarget
Volume7
Issue number49
DOIs
StatePublished - 2016

Keywords

  • Esophageal adenocarcinoma
  • Prognostic marker
  • miR-652-5p
  • miR-7-2-3p
  • miRNA

ASJC Scopus subject areas

  • Oncology

Fingerprint Dive into the research topics of 'Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma'. Together they form a unique fingerprint.

  • Cite this

    Matsui, D., Zaidi, A. H., Martin, S. A., Omstead, A. N., Kosovec, J. E., Huleihel, L., Saldin, L. T., DiCarlo, C., Silverman, J. F., Hoppo, T., Finley, G. G., Badylak, S. F., Kelly, R. J., & Jobe, B. A. (2016). Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma. Oncotarget, 7(49), 81281-81291. https://doi.org/10.18632/oncotarget.12832